Ventripoint: Uplisting To The OTCQB – The Daily Dive
Today on the Daily Dive, we are joined by George Adams, Chairman of Ventripoint Diagnostics (TSXV: VPT). George joins us
Read more
Ventripoint Diagnostics
Ventripoint Receives Further Funding From National Research Council of Canada
Ventripoint Diagnostics (TSXV: VPT) this morning had a brief release, indicating the firm has received further research funding. The latest
Read more
Ventripoint Looks To Raise $5.0 Million Via Bought Deal
Ventripoint Diagnostics (TSXV: VPT) this evening was halted for trading, ahead of announcing that the company will be conducting a
Read more
George Adams: COVID-19 Damages The Heart – The Daily Dive
Today’s Daily Dive welcomes back Dr. George Adams, Executive Chairman of VentriPoint Diagnostics (TSXV: VPT). He expounds on salient topics
Read more
VentriPoint Diagnostics: Corporate Overview
VentriPoint Diagnostics Ltd. (TSXV: VPT) is a small-cap medical device company that develops and commercializes cardiac diagnostic tools. VentriPoint is considered an
Read more
Ventripoint Diagnostics To Collaborate With GE Healthcare
Ventripoint Diagnostics (TSXV: VPT) this morning announced a major arrangement. The company has officially entered into a collaboration with that
Read more
Ventripoint Diagnostics: Using AI To Analyze The Heart – The Daily Dive feat George Adams
Today on the Daily Dive, our host Cassandra Leah sits down with George Adams, Executive Chairman of Ventripoint Diagnostics (TSXV:
Read more
Ventripoint Files For Provisional Patent On Heart Motion Tracking Tech
Ventripoint Diagnostics (TSXV: VPT) is evidently looking to grow its portfolio of intellectual property. The company this morning announced that
Read more
Ventripoint Joint Venture Begins Device Certification For Use In Covid Patients In China
Ventripoint Diagnostics (TSXV: VPT) is progressing with its joint venture partner in China. This morning the firm revealed that its
Read more
Ventripoint Sees First Commercial Sales In China Through Joint Venture
Ventripoint Diagnostics (TSXV: VPT) this morning issued a brief press release related to its joint venture based in China. The
Read more